middle.news
Imagion Biosystems Advances Toward FDA Trial with New US Leadership
10:00am on Thursday 29th of January, 2026 AEDT
•
Healthcare
Read Story
Imagion Biosystems Advances Toward FDA Trial with New US Leadership
10:00am on Thursday 29th of January, 2026 AEDT
Key Points
MagSense® HER2 imaging agent manufacturing and testing completed
IND submission to US FDA expected imminently
Optimised MRI protocols developed with Wayne State University
Ward Detwiler appointed President of US subsidiary
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
IMAGION BIOSYSTEMS (ASX:IBX)
OPEN ARTICLE